An analog of dolastatin 10, TZT-1027 (auristatin PE or soblidotin), which differs from dolastatin 10 only in the absence of the thiazoline ring from the dolaphenine residue, was found to be effective in two human xenograft models, MX-1 breast carcinoma and LX-1 lung carcinoma in mice.29